Pushing the treatment envelope for chronic hepatitis C—is more necessarily better?†‡
Open Access
- 19 January 2005
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 41 (2) , 234-236
- https://doi.org/10.1002/hep.20605
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- High‐dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C†Hepatology, 2005
- Treatment With Pegylated Interferon and Ribavarin in Hcv Infection With Genotype 2 Or 3 for 14 Weeks: A Pilot StudyHepatology, 2004
- Cost-Effectiveness of Combination Peginterferon alpha-2a and Ribavirin Compared With Interferon alpha-2b and Ribavirin in Patients With Chronic Hepatitis CAmerican Journal of Gastroenterology, 2004
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected PatientsNew England Journal of Medicine, 2004
- Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected PersonsNew England Journal of Medicine, 2004
- Peginterferon Alfa-2b and Ribavirin for the Treatment of Chronic Hepatitis C in Blacks and Non-Hispanic WhitesNew England Journal of Medicine, 2004
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialPublished by Elsevier ,2001
- The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis CGastroenterology, 2000